Cvs Health (CVS) Asset Writedowns and Impairment (2022 - 2024)

Cvs Health's Asset Writedowns and Impairment history runs 3 years deep, the most recent figure standing at -$840.0 million for Q4 2024.

• Quarterly Asset Writedowns and Impairment fell 326.4% year-over-year to -$840.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$430.0 million (down 362.2% YoY) and the FY2023 annual result came in at $152.0 million, down 94.0% from the prior year.
• Asset Writedowns and Impairment was -$840.0 million for Q4 2024 at Cvs Health, down from $607.0 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $2.5 billion in Q3 2022 and bottomed at -$840.0 million in Q4 2024.
• A 3-year average of $350.3 million and a median of $41.0 million in 2022 frame the typical range for Asset Writedowns and Impairment.
• Peak annual rise in Asset Writedowns and Impairment reached 751.22% in 2023, while the deepest fall reached 1741.67% in 2023.
• Cvs Health's Asset Writedowns and Impairment stood at $12.0 million in 2022, then sank by 1741.67% to -$197.0 million in 2023, then slumped by 326.4% to -$840.0 million in 2024.
• Business Quant data shows CVS's Asset Writedowns and Impairment at -$840.0 million in Q4 2024, $607.0 million in Q3 2024, and -$197.0 million in Q4 2023.